Blake Borgeson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Blake Borgeson is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 7.07 Million shares of RXRX, which is worth approximately $40.3 Million. The most recent transaction as insider was on Jan 09, 2024, when has been sold 20,054 shares (Class A Common Stock) at a price of $13.51 per share, resulting in proceeds of $270,929. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.07M

0.93% 3M change

4.61% 12M change

Total Value Held $40.3 Million

Blake Borgeson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 09 2024	SELL Open market or private sale	$270,929 $13.51 p/Share	20,054 Reduced 0.27%	7,344,418 Class A Common Stock
Dec 26 2023	SELL Open market or private sale	$213,174 $10.63 p/Share	20,054 Reduced 0.27%	7,364,472 Class A Common Stock
Dec 12 2023	SELL Open market or private sale	$84,707 $7.4 p/Share	11,447 Reduced 0.15%	7,384,526 Class A Common Stock
Nov 28 2023	SELL Open market or private sale	$76,923 $6.72 p/Share	11,447 Reduced 0.15%	7,395,973 Class A Common Stock
Nov 14 2023	SELL Open market or private sale	$56,153 $6.32 p/Share	8,885 Reduced 0.12%	7,407,420 Class A Common Stock
Oct 31 2023	SELL Open market or private sale	$46,823 $5.27 p/Share	8,885 Reduced 0.12%	7,416,305 Class A Common Stock
Oct 17 2023	SELL Open market or private sale	$58,463 $6.58 p/Share	8,885 Reduced 0.12%	7,425,190 Class A Common Stock
Oct 03 2023	SELL Open market or private sale	$64,771 $7.29 p/Share	8,885 Reduced 0.12%	7,434,075 Class A Common Stock
Sep 19 2023	SELL Open market or private sale	$74,278 $8.36 p/Share	8,885 Reduced 0.12%	7,442,960 Class A Common Stock
Sep 05 2023	SELL Open market or private sale	$78,099 $8.79 p/Share	8,885 Reduced 0.12%	7,451,845 Class A Common Stock
Aug 22 2023	SELL Open market or private sale	$79,165 $8.91 p/Share	8,885 Reduced 0.12%	7,460,730 Class A Common Stock
Aug 08 2023	SELL Open market or private sale	$202,400 $11.39 p/Share	17,770 Reduced 0.24%	7,469,615 Class A Common Stock
Jul 25 2023	SELL Open market or private sale	$273,484 $14.61 p/Share	18,719 Reduced 0.25%	7,487,385 Class A Common Stock
Jul 11 2023	SELL Open market or private sale	$61,217 $6.89 p/Share	8,885 Reduced 0.12%	7,520,104 Class A Common Stock
Jun 29 2023	SELL Bona fide gift	-	14,000 Reduced 0.19%	7,506,104 Class A Common Stock
Jun 27 2023	SELL Open market or private sale	$65,660 $7.39 p/Share	8,885 Reduced 0.12%	7,528,989 Class A Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	12,612 Added 0.17%	7,537,874 Class A Common Stock
Jun 13 2023	SELL Open market or private sale	$154,540 $9.98 p/Share	15,485 Reduced 0.21%	7,525,262 Class A Common Stock
May 30 2023	SELL Open market or private sale	$78,099 $8.79 p/Share	8,885 Reduced 0.12%	7,540,747 Class A Common Stock
May 16 2023	SELL Open market or private sale	$45,224 $5.09 p/Share	8,885 Reduced 0.12%	7,549,632 Class A Common Stock
Apr 18 2023	SELL Open market or private sale	$52,688 $5.93 p/Share	8,885 Reduced 0.12%	7,558,517 Class A Common Stock
Apr 04 2023	SELL Open market or private sale	$58,019 $6.53 p/Share	8,885 Reduced 0.12%	7,567,402 Class A Common Stock
Mar 21 2023	SELL Open market or private sale	$65,749 $7.4 p/Share	8,885 Reduced 0.12%	7,576,287 Class A Common Stock
Mar 07 2023	SELL Open market or private sale	$74,012 $8.33 p/Share	8,885 Reduced 0.12%	7,585,172 Class A Common Stock
Feb 21 2023	SELL Open market or private sale	$68,681 $7.73 p/Share	8,885 Reduced 0.12%	7,594,057 Class A Common Stock

Blake Borgeson

Director

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account